BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

E.I. DuPont de Nemours and Company


Contact Details:
Experimental Station 304/A230, P.O. Box 80304
Wilmington
DE
19880-0304
United States of America
Tel:(302) 695-2189
Fax:(302) 695-4414
Email:
WWW:

www.dupont.com/
Loading...

Recent Publications by E.I. DuPont de Nemours and Company:

Using genetic variation to optimize nutritional preemption.
One of the promises of nutritional genomics is a set of dietary...		28th March, 2007
Central Research and Development, E.I. duPont de Nemours and Company, J Nutr. 2007 Jan;137(1 Suppl):270S-274S.
Characterization of the structure and composition of gecko adhesive setae.
The ability of certain reptiles to adhere to vertical (and hang from...		20th July, 2006
E.I. DuPont de Nemours and Company Central Research and Development J R Soc Interface. 2006 Jun 22;3(8):441-51.
DOI Direct Link
Acute, subchronic, and mutagenicity studies with norbornene fluoroalcohol.
The object of this study was to evaluate the toxicity of norbornene...		24th December, 2005
E. I. DuPont de Nemours and Company, Haskell Laboratory for Health and Drug Chem Toxicol. 2005;28(4):379-95.
DOI Direct Link
Proposed involvement of a soluble methane monooxygenase homologue in the cyclohexane-dependent growth of a new Brachymonas species.
High-throughput mRNA differential display (DD) was used to identify genes...		22nd July, 2005
E. I. Dupont de Nemours and Company, Central Research and Development, Environ Microbiol. 2005 Feb;7(2):179-90.
DOI Direct Link
Developmental toxicity study of dimethylpiperidone.
The potential maternal and developmental toxicity of dimethylpiperidone...		8th October, 2004
Haskell Laboratory for Health and Environmental Sciences, E. I. duPont de Drug Chem Toxicol. 2004 Feb;27(1):1-14.

→View more E.I. DuPont de Nemours and Company research publications.

BioNews Results for E.I. DuPont de Nemours and Company:

Cauthen, Kenneth
Delaware Online:  May 21 2008 9:41AM Matching: e dupont de nemours company

E.I. DuPont de Nemours and Company Patents:

US Patent No.Title
4115408 Conversion of poly(tetramethylene ether) glycol in aqueous effluent stream to tetrahydrofuran
6221970 Curable perfluoroelastomer composition
6333412 Process for the preparation of .epsilon.-caprolactam
6372484 Apparatus for integrated polymerase chain reaction and capillary electrophoresis
6410619 Method for conditioning organic pigments

→View more E.I. DuPont de Nemours and Company patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 16 individuals from E.I. DuPont de Nemours and Company using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 310 times since April 2007, the link to the organisation's website has been followed 61 times

Recent Search Terms used to find this page: E.I. duPont Nemours locations | f | .

Search for more companies in Wilmington

Search for more companies in DE



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for E.I. DuPont de Nemours and Company
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.